Delivery Order SPE2DB22D2211-SPE2DB25FSCCJ
- Not listed
- The Defense Logistics Agency (DLA) awarded a $1,969.36 delivery order to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes, with an ultimate completion date of September 3, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child delivery order issued under a larger indefinite delivery contract (IDC) vehicle, leveraging the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,365.90 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes, with a completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $9,106.00 to AmerisourceBergen Drug Corp for the supply of RhoGAM Ultra-Filtered Plus syringes under contract 4569065080. The contract is a firm fixed price delivery order with an ultimate completion date of September 3, 2025, and represents a non-competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location in that same city. This delivery order is...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a medical product. The delivery order has a firm fixed price of $1,969.36 and a period of performance through May 27, 2025. This order is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RHOGAM ULTRA-FILTERED PLUS SYRS, a pharmaceutical product. The contract has a firm fixed price of $1,138.25 and a completion date of July 24, 2025. It is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $1,160.50 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply RHOGAM ULTRA-FILTERED PLUS syringes. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a DLA facility located in Conshohocken, Pennsylvania by January 5, 2024. No set-aside designation was applied to this award made under an existing indefinite delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of pharmaceutical products and medical supplies, including Rho(D) Immune Globulin Intravenous (Human) RHOGAM ULTRA-FILTERED PLUS SYRS. The contract has a ceiling value of $2,360.40 and a completion date of May 20, 2024. The contract is a firm fixed price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a...
- The Defense Logistics Agency awarded a $1,434.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Rhophylac 300 MCG/2 ML syringes on July 22, 2025, with an ultimate completion date of August 12, 2025. This non-set-aside delivery order represents a pediatric immunoglobulin product sourced through AmerisourceBergen's extensive federal pharmaceutical supply network. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rhophylac 300 mcg/2 mL syringes, with a ceiling value of $10,755.00. The contract, awarded on July 25, 2025, carries a firm fixed price structure with an ultimate completion date of August 15, 2025. This delivery order does not utilize a set-aside designation and represents a competitive award to the prime contractor, whose corporate office is located in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $7,325.64 to AmerisourceBergen Drug Corp for GAMUNEX-C, a 10 gram/100 mL immunoglobulin vial product, with an ultimate completion date of August 21, 2025. This competitive award, issued on July 31, 2025, utilizes a firm fixed price contract type with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCCJDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,969.36 to AmerisourceBergen Drug Corp for RhoGAM Ultra-Filtered Plus syringes. This firm fixed-price contract, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award falls within AmerisourceBergen's broader pharmaceutical supply mission, which includes delivering medications, vaccines, and specialized medical supplies to support military and federal healthcare systems. This delivery order is issued under AmerisourceBergen's prime indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. RhoGAM Ultra-Filtered Plus is an anti-D immunoglobulin product used in obstetric and hematologic applications, demonstrating AmerisourceBergen's role in delivering specialized pharmaceutical products critical to federal military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/4/25 |